FDA Expanded Access Pathways

Posted 16 November 2015 By Rachelle D'Souza

placeholder+image This article discusses the various US regulatory pathways for access to investigational drugs and medical devices outside a clinical trial.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Regulatory strategy, Features, US, FDA

Tags: Expanded Access

Regulatory Exchange: Latest Updates From the Community